Tarsus Pharmaceuticals Inc (TARS) — Long-term Investment Intensity
Tarsus Pharmaceuticals Inc (TARS) has a Long-term Investment Intensity of 0.7% as of March 2026. Long-term investments of $3.87 Million represent 0.7% of total assets of $581.13 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Tarsus Pharmaceuticals Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Tarsus Pharmaceuticals Inc Long-term Investment Intensity (2022–2025)
This chart shows how Tarsus Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2022 to 2025. As of March 2026, the intensity stands at 0.7%, reflecting long-term investments of $3.87 Million against total assets of $581.13 Million USD. Explore TARS operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Tarsus Pharmaceuticals Inc (2022–2025)
The table below presents the year-by-year Long-term Investment Intensity for Tarsus Pharmaceuticals Inc from 2022 to 2025, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Tarsus Pharmaceuticals Inc market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 0.7% | $3.87 Million | $562.16 Million | ▼ -0.1 pp |
| 2024 | 0.8% | $3.00 Million | $376.99 Million | ▲ +0.6 pp |
| 2023 | 0.2% | $631.00K | $265.49 Million | ▲ +0.1 pp |
| 2022 | 0.2% | $371.00K | $227.86 Million | — |